Phase II study of cetuximab as monotherapy and first-line treatment in patients with locally advanced or metastatic squamous cell carcinoma of the skin expressing EGFR [epidermal growth factor receptor]
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cetuximab (Primary)
- Indications Skin cancer
- Focus Therapeutic Use
- Acronyms CTXSCC
- 22 Feb 2012 Biomarkers information updated
- 02 Sep 2009 Actual end date (1 Jun 2009) added as reported by ClinicalTrials.gov.
- 01 Sep 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.